During the past decade, Deventer Ziekenhuis conducted 67 clinical trials. In the 10-year time frame, 67 clinical trials started and 8 clinical trials were completed, i.e. on average, 11.9% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 3 clinical trials were completed. i.e. 11.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Deventer Ziekenhuis" #1 sponsor was "The Netherlands Cancer Institute" with 15 trials, followed by "Radboud University Medical Center" with 6 trials sponsored, "Borstkanker Onderzoek Groep" with 4 trials sponsored, "University Medical Center Groningen" with 4 trials sponsored and "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 4 trials sponsored. Other sponsors include 70 different institutions and companies that sponsored additional 60 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Deventer Ziekenhuis" #1 collaborator was "Borstkanker Onderzoek Groep" with 8 trials as a collaborator, "Dutch Cancer Society" with 6 trials as a collaborator, "AstraZeneca" with 5 trials as a collaborator, "Bayer" with 5 trials as a collaborator and "Roche Pharma AG" with 5 trials as a collaborator. Other collaborators include 171 different institutions and companies that were collaborators in the rest 147 trials.

According to Clinical.Site data, the most researched conditions in "Deventer Ziekenhuis" are "Breast Cancer" (10 trials), "Heart Failure" (7 trials), "Colorectal Cancer" (4 trials), "Atherosclerotic Cardiovascular Disease" (3 trials) and "Atrial Fibrillation" (3 trials). Many other conditions were trialed in "Deventer Ziekenhuis" in a lesser frequency.

Most popular intervention types in "Deventer Ziekenhuis" are "Drug" (61 trials), "Other" (27 trials), "Procedure" (9 trials), "Device" (7 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Cyclophosphamide" (3 trials), "Paclitaxel" (3 trials), "Accelerated medical clearance and surgery" (2 trials) and "Bevacizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Deventer Ziekenhuis" are 87 trials for "All" genders, 15 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are 47 active trials in "Deventer Ziekenhuis". 1 are not yet recruiting, 28 are recruiting, 16 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 44 completed trials in Deventer Ziekenhuis, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Deventer Ziekenhuis, 2 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 22 trials that are defined as “Not Applicable".